Pfizer Covid jabs highly effective in elderly: UK study
Health & Lifestyle || shiningbd
The Pfizer and Oxford-AstraZeneca vaccines have been "highly effective" in reducing coronavirus infections and severe illness among elderly people in Britain, with a more than 80 percent reduction in hospitalization, official data showed Monday.
In the over 80s, a single dose of either vaccine is more than 80 percent effective at preventing hospitalization around three to four weeks after the jab, according to a Public Health England real-world study that has gathered data since January.
The study comes as France and Germany consider reversing their refusal to authorize the AstraZeneca vaccine for people over 65 due to concerns about its efficacy.
British Health Secretary Matt Hancock hailed the new study as "extremely good news". "The detailed data show that the protection that you get from catching Covid 35 days after a first jab is even slightly better for the Oxford jab than for Pfizer," he added.
Both vaccines "are highly effective in reducing COVID-19 infections among older people aged 70 years and over," added the study.
The Pfizer jab has offered protection against catching the disease of between 57 and 61 percent after the first dose, with the AstraZeneca vaccine offering protection of between 60 and 73 percent, according to the study.
"This adds to growing evidence showing that the vaccines are working to reduce infections and save lives," said Mary Ramsay, Public Health England's head of immunisation.
"It is important to remember that protection is not complete and we don't yet know how much these vaccines will reduce the risk of you passing COVID-19 onto others," she added.